Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-04-12 Novartis Bioventures Ltd 10% owner Purchase +300,000 $10.00 $3.0M 2,310,924
2016-04-12 Novartis Bioventures Ltd 10% owner Conversion · Series A Preferred Stock −890,476 0
2016-04-12 Novartis Bioventures Ltd 10% owner Conversion · Series B Preferred Stock −1,120,448 0
2016-04-12 Lowe David George CEO and President Conversion +5,658 5,658
2016-04-12 Lowe David George CEO and President Conversion · Series A Preferred Stock −2,857 0
2016-04-12 Lowe David George CEO and President Conversion · Series B Preferred Stock −2,801 0
2016-04-12 Cox Russell J. Director Purchase +7,000 $10.00 $70K 7,000

Page 21 of 21 · 407 trades